Download SAONS Meeting

SAONS Meeting
December 15, 2010. 1800-2000.
Topic: “Case Studies in the Proactive Management of Multiple Myeloma”
I believe all of us have taken care of patients with multiple myeloma. This cancer affects older adults.
Due to longevity we will undoubtedly take care of these patients more and more.
Our speaker is Jacy Spong, RN, BSN, OCN®. She is a hematology oncology nurse working at the Mayo
Clinic in Scottsdale, Arizona. She is very knowledgeable about Multiple Myeloma. We are thankful to have
her as our speaker at our 12/15/2010 meeting.
I would like to share with you some information about Multiple Myeloma that will entice you to
learn more about this topic!
Multiple Myeloma:













Greek myelo—bone marrow.
Lymphoid stem cells differentiate in to T and B cell lymphocytes.
Multiple myeloma is a cancer of plasma cell or plasma B cells. Also known as plasma cell
myeloma or Kahler’s disease.
Plasma cells are the white blood cells that are responsible for the production of antibodies.
Cancer of the B cells (plasma cells) results in many issues. B cells produce protein antibody
which affects the immune system.
Infection is a big threat to patients with multiple myeloma
Such collections of abnormal cells cause (bone) lesions in the bones, and in the bone marrow
they interfere with the production of normal cells.
Cases of myeloma can feature the production of a paraprotein…an abnormal antibody that can
cause kidney problems as well as interfere of with production of normal antibodies leading to
immunodeficiency. In addition hypercalcemia is often seen as well.
Diagnosis is done with protein electrophoresis and peripheral smear blood, bone marrow
biopsy, and X-rays of involved bones.
Some of the treatment modalities: steroids, chemotherapy, thalidomide, stem cell transplants.
Radiation therapy used to treat bone lesions that cause symptoms.
Sign and symptoms: CRAB; C= Calcium (high), R= Renal failure, A= Anemia, B= Bone
lesions…these symptoms involving many organs in the body.
Additional neurological symptoms are confusion, weakness, fatigue, headache, visual change,
retinopathy.
Due to low or lack of immunity/antibodies myeloma patients suffer from various infections:
pneumonias, pyelonephritis. The risk of infection is much higher after the patient receives the
initial chemotherapy.
1








Approximately 45,000 people in US are living with multiple myeloma with 14,600 new cases
diagnosed each year.
Multiple myeloma is the second most prevalent blood cancer (10%) after non-Hodgkin’s
lymphoma.
Multiple myeloma is about 1% of all cancer, and 2% of all cancer deaths.
The peak age is 65-70 years of age, seen in men more than women.
African American and Native Pacific Islanders have the highest reported incidence in US.
9.5 cases per 100,000 African American and 4.1% per 100,000 Caucasian. Among African
American, myeloma is one to the top 10 leading causes of cancer deaths.
Are you excited yet???
My understanding is that this is the CEU presentation…an icing to the cake!
Now let me introduce you to our speaker.
Jacy Spong, RN, BSN, OCN®’ brief bio is below:
Jacy Spong, RN, BSN, OCN®, received her BSN from Creighton University in Omaha, Nebraska. She
worked in the Bone Marrow Transplant Unit at UCSF Medical Center in San Francisco prior to
coming to the Mayo Clinic in Scottsdale, Arizona, where she works in hematology and oncology.
Jacy is both chemotherapy and OCN certified through ONS. She is a member of ONS and the
Phoenix Chapter of the ONS, where she serves as the Mayo correspondent. Jacy is also a member of
the International Myeloma Foundation Nurse Leadership Board.
Enjoy Learning!
See you at the meeting!
Piya Shult
………………………………………………………………………………………………………
Our meeting is scheduled for Wednesday, December 15, 2010 at 1800-2000 at Kingfisher
2564 East Grant Road, Tucson, AZ (520) 323-7739
RSVP to Kim Faber, SAONS Membership Chair: [email protected]
Cathy Parsons, SAONS Program Director
2